All News Hainan Poly Pharm. Co., Ltd

Equities

300630

CNE100002N10

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
12.35 ^CNY	-18.75%		-.--%	-45.40%

14/05	China Grants Registration Approval for Antibacterial Drug	MT
06/05	Hainan Poly Pharm Gets GMP Certificate From Saudi Authorities	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Grants Registration Approval for Antibacterial Drug	14/05	MT
Hainan Poly Pharm Gets GMP Certificate From Saudi Authorities	06/05	MT
Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Sweden	08/04	MT
Hainan Poly Pharm Gets Nod to Market Skin Infection Drug in Germany	04/04	MT
Hainan Poly Pharm's Brivaracetam Injection Gets FDA's Nod to Enter US Market; Shares Up 3%	04/03	MT
Hainan Poly Pharm's Epilepsy Drug Gets FDA's Greenlight to Enter US Market	19/02	MT
Hainan Poly Pharm to Apply For Up to 3.8 Billion Yuan Credit Line	11/01	MT
Hainan Poly Pharm Gets Nod to Market Pantoprazole Sodium for Injection in Singapore	12/12	MT
Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component A Share Index	11/12	CI
Hainan Poly Pharm. Co., Ltd(SZSE:300630) dropped from Shenzhen Stock Exchange Component Index	11/12	CI
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
Hainan Poly Pharm's Gets US FDA Nod to Market Iopamidol Injection	09/23/09	MT
Hainan Poly Pharm Gets Approval to Market Fluconazole Dry Suspension in US	25/23/25	MT
Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.	15/23/15	CI
Hainan Poly Pharm. Co., Ltd's Equity Buyback announced on April 25, 2023 has closed with 1,426,700 shares, representing 0.33% for CNY 30.03 million.	14/23/14	CI
Hainan Poly Pharm's Unit Passes US FDA's On-Site Inspection	11/23/11	MT
Hainan Poly Pharm. Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Hainan Poly Pharm's Unit Passes Regulator's GMP Inspection	07/23/07	MT
Hainan Poly Pharm Wins FDA Nod to Market Azithromycin Variant in US	31/23/31	MT
Hainan Poly Pharm. Co., Ltd Announces Dividend Implementation of Cash Dividend for 2022, Payable on 18 July 2023	12/23/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Hainan Poly Pharm. Co., Ltd

Equities

300630

CNE100002N10

All News

Filters